Evidence map›Paper›PMID 19258004›Full record

ArticleAnalytical biochemistry2009

Chemically modified primers for improved multiplex polymerase chain reaction.

Jonathan Shum, Natasha Paul

Abstract read
In one paragraph

Article in Analytical biochemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Malaria diagnostic update: From conventional to advanced method.Journal of clinical laboratory analysis · 2022
    Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jonathan ShumDepartment of Research and Development, TriLink BioTechnologies, San Diego, CA 92121, USA.
Natasha Paul

Funding

Chemically Modified Primers for Improved Hot Start PCRR44GM072177 · NIGMS · TRILINK BIOTECHNOLOGIES, INC. · PI LEBEDEV, ALEXANDRE · 2006 to 2007
$749k
Chemically Modified Primers for Improved Hot Start PCRR43GM072177 · NIGMS · TRILINK BIOTECHNOLOGIES, INC. · PI LEBEDEV, ALEXANDRE · 2005 to 2005
$99k
NIGMS NIH HHS 1R43 GM 072177-01A1NIGMS NIH HHS 2R44 GM 072177-02NIGMS NIH HHS 5R44 GM 072177-03NIGMS NIH HHS R43 GM072177NIGMS NIH HHS R44 GM072177
6 · The paper itself

Abstract

Multiplex polymerase chain reaction (PCR), the amplification of multiple targets in a single reaction, presents a new set of challenges that further complicate more traditional PCR setups. These complications include a greater probability for nonspecific amplicon formation and for imbalanced amplification of different targets, each of which can compromise quantification and detection of multiple targets. Despite these difficulties, multiplex PCR is frequently used in applications such as pathogen detection, RNA quantification, mutation analysis, and (recently) next generation DNA sequencing. Here we investigated the utility of primers with one or two thermolabile 4-oxo-1-pentyl phosphotriester modifications in improving multiplex PCR performance. Initial endpoint and real-time analyses revealed a decrease in off-target amplification and a subsequent increase in amplicon yield. Furthermore, the use of modified primers in multiplex setups revealed a greater limit of detection and more uniform amplification of each target as compared with unmodified primers. Overall, the thermolabile modified primers present a novel and exciting avenue for improving multiplex PCR performance.

Indexed as

DNA PrimersPolymerase Chain ReactionDNA Primers

Identifiers

PMID19258004
PMCPMC2716723

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.